Interim Vice-Dean (International)
Faculty of Life Sciences & Medicine King’s College London
London, SE1 9NH, UK.
Dr Richard Siow graduated from King’s College London (KCL) in 1993 with a BSc in Nutrition and subsequently obtained a PhD in Physiology in 1996 at the Centre for Cardiovascular Biology and Medicine, KCL. Following postdoctoral positions at KCL and University of Cambridge, Richard returned to KCL in 2001 and is currently Senior Lecturer in the Cardiovascular Division, British Heart Foundation Centre of Research Excellence and Vice-Dean (International) for the Faculty of Life Sciences & Medicine at KCL. He is also the Committee Chair of Ageing Research at King’s (ARK), a cross-Faculty consortium of researchers taking a multidisciplinary approach to better understand the mechanisms of ageing and related diseases to improve health-span, clinical translation and the social impact of ageing.
Dr Siow’s research programme at KCL focuses on cardiovascular cell biology and nutrigenomics. His current projects investigate the role of phytonutrients on the function of vascular endothelial and smooth muscle cells, cardiac myocytes, mesenchymal stem cells, adventitial and dermal fibroblasts. His research themes include the impact of physiological oxygen levels and biomechanics on cellular and molecular responses to oxidative stress and induction of endogenous antioxidant defences in ageing to assess therapeutic strategies for cardiovascular and tissue regeneration. His research is funded by British Heart Foundation, Heart Research UK, BBSRC and Innovate UK. In addition, he has established collaborative research programs with Unilever R&D since 2008. Dr Siow is currently an Associate Editor of Frontiers in Nutrigenomics and a member of the Editorial Board of Free Radical Research and Oxidative Medicine and Cellular Longevity. He is currently a committee member of the European and British Microcirculation Societies, Nutrition Society and an Elected Fellow of the Royal Society of Biology. Past committee memberships include the Physiological Society, Society for Free Radical Research – International and British Atherosclerosis Society.
Dr Siow’s election to the EVBO Council will benefit the membership through his involvement with the European Microcirculation Society Committee, as it is likely that future EVBO and ESM activities will remain closely aligned. Through his extensive background in cardiovascular redox biology and nutrigenomics, these fields could be developed for future EVBO meeting themes. Richard is committed to the support of early career investigators which will foster future pan-European research excellence in vascular biology. This will be facilitated through joint ESM and EVBO Summer Schools to establish international networks of basic and clinical early career researchers in vascular biology and related fields. The future of EVBO would also benefit from establishing partnerships with other European Societies (e.g. Society for Free Radical Research, European Atherosclerosis Society, The Physiological Society and FEPS) which will broaden the horizon of EVBO and attract a wider membership with new areas of expertise over the next few years.